Joint Formulary & PAD

White Birch pollen allergen extract - Allergic rhinitis

You are here : Home > Formulary Search > White Birch pollen allergen extract - Allergic rhinitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral lyophilisates
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
NICE
R
SPC
Restrictions / Comments :
Important

BLUE for ADULTS only. To be initiated by Specialist Immunology only - transfer to primary care can occur after 1 month.

Maximum of 3 years course only (SPC), clear instruction for how to stop to be in clinic letter.

 

Status 2

Red
Formulations :
  • Oral lyophilisates
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
R
SPC
Restrictions / Comments :
Important

RED for ages 5 to 18 years only.

Specialist immunology only

Documentation

NICE Technology Appraisal
NICE TA1087 Itulazax for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen in adults
Evidence Review
NICE TA1087 Itulazax for allergic rhinitis in Adults Nov-25 Briefing paper.doc

PAD Profile

ChemicalSubstance :
White Birch pollen allergen extract
Indication :
Allergic rhinitis
Group Name :
Keywords :
allergic disorders, allergens, allergen therapy, hyposensitising agents, tree pollen allergy, allergic conjunctivitis
Brand Names Include :
Itulazax
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Allergic rhinitis
Supporting Documents :
2
Traffic Light Entries :
2

Committee Recommendations (3)

05 Nov 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee assigned a RED traffic light status for the treatment of allergic rhinitis or conjunctivitis in patients under the age of 18 years, whilst awaiting a NICE Technology Appraisal  in Summer 2026.

05 Nov 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves betula verrucosa (Itulazax 12 SQ Bet) for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen in line with NICE TA1087.

A BLUE (with specialist team initiation) traffic light status has been agreed with at least 1 month prescribing by the specialist team to enable review and confirmation of clinical benefit, prior to transfer of care to Primary Care.

Follow up appointments will be managed by the specialist immunology team who will assess for continued clinical benefit.

03 Oct 25 - RSFT DTC

Previously approved for adults. now approved for over 5 years

Other Indications

Below are listed other indications that White Birch pollen allergen extract is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Allergic rhinitis.